Skip to main content

Table 2 Baseline of DM population

From: Could remnant-like particle cholesterol become a risk factor in diabetic menopausal women with coronary artery disease? A cross-sectional study of single academic center in China

 

DM Total

(n = 1496)

non-CAD

(n = 465)

CAD

(n = 1031)

P value

Age, years

65.02 ± 7.17

64.70 ± 7.35

65.16 ± 7.09

0.252

BMI, kg/m2

25.34 ± 3.39

25.24 ± 3.10

25.39 ± 3.52

0.433

SBP, mmHg

129.16 ± 15.47

127.35 ± 14.81

129.97 ± 15.70

0.002

DBP, mmHg

75.19 ± 11.44

73.95 ± 11.36

75.74 ± 11.43

0.005

Smoking, n(%)

85 (5.68)

21 (4.52)

64 (6.21)

0.191

Drinking, n(%)

2 (0.13)

0 (0.00)

2 (0.19)

0.342

Medical history, n(%)

 HT, n (%)

1176 (78.61)

363 (78.06)

813 (78.86)

0.730

 Hyperlipidemia, n(%)

606 (40.51)

190 (40.86)

416 (40.35)

0.852

 Family history of CVD, n(%)

70 (4.68)

23 (4.95)

47 (4.56)

0.743

Laboratory results

 TC, mmol/L

4.36 ± 1.09

4.34 ± 1.05

4.37 ± 1.11

0.708

 TG, mmol/L

1.86 ± 1.34

1.76 ± 1.03

1.91 ± 1.45

0.048

 LDL-C, mmol/L

2.54 ± 0.87

2.53 ± 0.84

2.54 ± 0.89

0.761

 HDL-C, mmol/L

1.08 ± 0.26

1.12 ± 0.29

1.06 ± 0.25

0.001

 non-HDL-C, mmol/L

3.28 ± 1.04

3.23 ± 1.02

3.31 ± 1.05

0.195

 RLP-C, mmol/L

0.74 ± 0.48

0.70 ± 0.42

0.76 ± 0.51

0.024

Medical treatment, n(%)

 Insulin

202 (13.50)

54 (11.61)

148 (14.35)

0.151

 Aspirin

1315 (87.90)

390 (83.87)

925 (89.72)

0.001

 Clopidogrel

981 (65.57)

212 (45.60)

769 (74.59)

<0.001

 Statins

1113 (74.40)

344 (73.98)

769 (74.59)

0.803

 β-blockers

938 (62.70)

289 (62.15)

649 (62.95)

0.768

 ARB

306 (20.45)

97 (20.86)

209 (20.27)

0.794

 ACEI

73 (4.88)

18 (3.87)

55 (5.33)

0.224

  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HT hypertension, CVD cardiovascular disease, CAD coronary artery disease, TC total cholesterol, TG triglyceride, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, RLP-C remnant-like particle cholesterol, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker